Clinical Trial Update: BeEAC Conditioning Regimen in Malignant Lymphoma Subjects With Indications to Autologous Hematopoietic Stem-cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BeEAC conditioning regimen in patients with relapsed/refractory malignant lymphoma undergoing autologous hematopoietic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• BeEAC conditioning regimen (BeEAC)

Snippet

Sponsor: State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | Conditions: Relapsed/Refractory Malignant Lymphomas | Phase 2 | Status: UNKNOWN